The latest agreement includes higher fees for overseas firms, hiring transparency requirements and greater use of real-world evidence.
Elise Reuter, MedTech Dive, August 10, 2026
U.S. companies will see few changes from the latest Medical Device User Fee Amendments, but overseas firms will face higher costs than under the current five-...